Beryl Drugs Ltd

Beryl Drugs Ltd

₹ 30.1 -2.65%
22 Jul - close price
About

Beryl Drugs Ltd is principally engaged in Manufacturing of Bulk Drugs. It was incorporated in 1993.[1]

Key Points

Product Offerings
The company offers a broad range of manufacturing options to clients such as small volume injectables in liquid and dry power form, variety of eye and ear drops, IV Fluids in polypack and glass bottles and variety of veterinary medicines.[1]

  • Market Cap 15.3 Cr.
  • Current Price 30.1
  • High / Low 45.0 / 14.2
  • Stock P/E 19.8
  • Book Value 17.6
  • Dividend Yield 0.00 %
  • ROCE 11.0 %
  • ROE 9.07 %
  • Face Value 10.0

Pros

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding is low: 26.4%
  • Company has a low return on equity of 3.70% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
5.67 4.65 3.38 3.22 3.52 4.97 7.90 8.19 6.09 8.18 8.09 7.66 3.21
5.43 3.94 3.47 2.97 3.81 4.37 7.27 7.47 5.82 7.05 7.37 6.87 3.19
Operating Profit 0.24 0.71 -0.09 0.25 -0.29 0.60 0.63 0.72 0.27 1.13 0.72 0.79 0.02
OPM % 4.23% 15.27% -2.66% 7.76% -8.24% 12.07% 7.97% 8.79% 4.43% 13.81% 8.90% 10.31% 0.62%
0.45 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.14 0.11 0.11 0.12 0.10 0.13 0.11 0.12 0.06 0.12 0.10 0.11 0.13
Depreciation 0.24 0.30 0.24 0.27 0.27 0.25 0.19 0.22 0.15 0.28 0.29 0.31 0.32
Profit before tax 0.31 0.30 -0.44 -0.14 -0.66 0.22 0.33 0.38 0.06 0.73 0.33 0.37 -0.43
Tax % 61.29% -13.33% -6.82% -28.57% -27.27% 0.00% -6.06% 60.53% -16.67% 27.40% 18.18% 16.22% -16.28%
0.12 0.34 -0.42 -0.10 -0.47 0.22 0.34 0.14 0.06 0.53 0.27 0.31 -0.35
EPS in Rs 0.24 0.67 -0.83 -0.20 -0.93 0.43 0.67 0.28 0.12 1.05 0.53 0.61 -0.69
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
14.42 14.54 13.23 12.99 10.90 15.08 12.81 12.78 14.03 14.48 26.84 27.13
13.50 13.77 12.50 12.49 10.96 14.04 11.78 11.87 12.58 14.04 24.84 24.46
Operating Profit 0.92 0.77 0.73 0.50 -0.06 1.04 1.03 0.91 1.45 0.44 2.00 2.67
OPM % 6.38% 5.30% 5.52% 3.85% -0.55% 6.90% 8.04% 7.12% 10.33% 3.04% 7.45% 9.84%
0.12 0.18 0.18 0.37 0.27 0.69 0.24 0.23 0.64 0.16 0.27 0.00
Interest 0.14 0.20 0.26 0.21 0.20 0.13 0.15 0.32 0.47 0.46 0.47 0.46
Depreciation 0.29 0.32 0.52 0.41 0.38 0.33 0.32 0.66 1.27 1.09 0.81 1.20
Profit before tax 0.61 0.43 0.13 0.25 -0.37 1.27 0.80 0.16 0.35 -0.95 0.99 1.01
Tax % 36.07% 37.21% 38.46% 32.00% 18.92% 22.05% 26.25% 68.75% 31.43% -30.53% 22.22% 23.76%
0.39 0.27 0.08 0.17 -0.45 0.99 0.59 0.05 0.24 -0.66 0.77 0.77
EPS in Rs 0.76 0.53 0.16 0.34 -0.89 1.95 1.16 0.10 0.47 -1.30 1.52 1.52
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: 6%
5 Years: 16%
3 Years: 25%
TTM: 1%
Compounded Profit Growth
10 Years: 11%
5 Years: 6%
3 Years: 113%
TTM: 0%
Stock Price CAGR
10 Years: 2%
5 Years: 38%
3 Years: 41%
1 Year: 96%
Return on Equity
10 Years: 3%
5 Years: 2%
3 Years: 4%
Last Year: 9%

Balance Sheet

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 5.06 5.09 5.09 5.09 5.09 5.09 5.09 5.09 5.09 5.09 5.09 5.09
Reserves 1.06 1.33 1.40 1.57 0.79 1.57 2.43 2.53 2.84 2.20 2.97 3.83
0.89 1.53 1.72 1.69 1.72 1.48 3.25 5.23 5.12 5.29 4.54 5.09
1.92 1.79 2.71 1.80 2.85 2.69 3.80 4.07 5.60 5.25 4.92 3.48
Total Liabilities 8.93 9.74 10.92 10.15 10.45 10.83 14.57 16.92 18.65 17.83 17.52 17.49
2.85 2.79 2.43 2.44 2.25 2.22 1.96 8.60 7.52 6.04 6.03 6.17
CWIP 0.00 0.13 0.24 0.00 0.00 0.08 6.24 0.00 0.00 0.00 0.00 0.00
Investments 1.24 0.73 0.68 0.68 0.49 0.22 0.48 0.56 0.12 0.16 0.15 0.00
4.84 6.09 7.57 7.03 7.71 8.31 5.89 7.76 11.01 11.63 11.34 11.32
Total Assets 8.93 9.74 10.92 10.15 10.45 10.83 14.57 16.92 18.65 17.83 17.52 17.49

Cash Flows

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
0.78 0.00 0.70 -0.13 0.37 -0.10 3.35 0.18 0.34 -0.29 2.48 0.82
-0.70 0.00 0.02 0.17 0.32 -0.03 -5.01 -1.55 0.26 0.54 -1.30 -1.08
0.08 0.00 -0.09 -0.23 -0.19 -0.36 1.62 1.67 -0.54 -0.43 -1.17 0.10
Net Cash Flow 0.16 0.00 0.63 -0.19 0.50 -0.49 -0.04 0.30 0.06 -0.18 0.01 -0.16

Ratios

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 56.70 64.26 102.08 100.59 102.47 116.91 98.02 98.53 118.11 112.17 93.83 101.98
Inventory Days 30.75 52.84 64.34 65.28 151.29 53.10 39.74 486.67 1,135.00 245.67 35.00
Days Payable 52.72 50.59 69.91 34.34 65.24 57.03 93.60 755.17 1,110.00 758.08 56.11
Cash Conversion Cycle 34.73 66.51 96.50 131.54 188.52 112.97 44.16 -169.97 143.11 112.17 -418.57 80.87
Working Capital Days 35.69 75.56 84.70 105.37 120.89 105.53 43.59 82.25 120.45 138.39 71.26 93.23
ROCE % 11.59% 8.42% 5.20% 5.56% -2.26% 11.94% 9.94% 4.06% 2.86% -3.82% 11.60% 11.05%

Shareholding Pattern

Numbers in percentages

2 Recently
Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
24.92% 24.92% 24.92% 24.92% 24.92% 24.92% 26.38% 26.38% 26.38% 26.38% 26.38% 26.38%
75.08% 75.08% 75.08% 75.08% 75.07% 75.07% 73.61% 73.61% 73.62% 73.62% 73.61% 73.61%
No. of Shareholders 6,8686,9746,9926,9786,9786,9396,8946,8006,8056,8527,2577,325

Documents